Abstract
Dendrimers with well-defined molecular structure and high monodispersity have gained tremendous interest in gene delivery. However, current gene carriers based on dendrimers are either not effective or are too toxic on the transfected cells. The efficacy and cytotoxicity of dendrimers are strongly correlated with their molecular weight or generation. High-generation dendrimers are reported with relatively high transfection efficacy but serious cytotoxicity due to the excess positive charges on the polymers, while low-generation dendrimers with minimal toxicity have poor polyplex stability and thus weak transfection efficacy. To break up the correlation between efficacy and toxicity, low-generation dendrimers were fabricated into various nanostructures by several strategies to improve their gene-binding capacity, polyplex stability, and transfection efficacy without inducing additional toxicity. In this review article, we will highlight recent advances in the development of assembled dendrimer nanostructures for efficient and non-toxic gene delivery. Specifically, the principles and strategies in the fabrication of dendrimer nanostructures are intensively reviewed.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
1 Introduction
Dendrimers are hyperbranched macromolecules with well-defined molecular structures, high monodispersity, and nanoscale size [1,2,3]. They are synthesized in a step-wise manner around a core [4]. During the synthesis, each successive reaction step leads to an additional generation of branching and the number of repeated steps is defined as dendrimer generation (denoted as G) [5]. Generally, dendrimers with G < 4 and G ≥ 4 are termed low- and high-generation dendrimers, respectively. Since the early 1990s, cationic dendrimers were widely used as non-viral vectors for gene delivery [6,7,8,9,10]. Generally, cationic dendrimers bind nucleic acids such as DNA and siRNA via ionic interactions, forming positively charged polyplexes. The polyplexes protect the nucleic acids from enzymatic degradation and favor their internalization by the target cells [11]. However, the polyplexes formed by ionic interactions are easily destabilized by salts, polyanionic proteins, and phospholipids abundant in biological systems [12]. As a result, low-generation dendrimers usually exhibit poor transfection efficacy, and high-generation ones with relatively high molecular weights and excess positive charges are used to increase the polyplex stability towards polyanionic molecules [6]. Though these dendrimers have increased transfection efficacy compared to low-generation ones, the excess of positive charges on the polyplexes usually lead to serious toxicity on the transfected cells (Fig. 1) [13,14,15,16]. The cytotoxicity of polymers is reported to increase with molecular weight and charge density [17,18,19]. Based on these rationales, there is an urgent need to break up the transfection efficacy-cytotoxicity correlation for cationic dendrimers in gene delivery [20]. Recently, low-generation dendrimers were fabricated into different nanostructures to dissolve the dilemma of balancing cytotoxicity and transfection efficiency for cationic dendrimers [21,22,23,24,25]. These fabricated nanostructures with limited positive charges can form stable polyplexes with DNA and siRNA in cell culture media, and further disassemble/degrade into low molecular weight species after cellular uptake [20, 21]. In this study, we will discuss the strategies in the fabrication of low-generation dendrimers for efficient and non-toxic gene delivery.
2 Assembling of Low-Generation Dendrimers into Nanostructures
Low-generation dendrimers can be fabricated into nanostructures via a supramolecular strategy. The dendrimers could be associated with each other in aqueous solutions via ionic, hydrogen-bonding, hydrophobic, or fluorophilic interactions [20, 23, 24, 26, 27]. When a G2 polyamidoamine (PAMAM) dendrimer was conjugated with an average number of seven phenylboronic acid moieties on its surface, the yielding zwitterionic dendrimer was clustered into nanoparticles around 100 nm via ionic interactions between phenylboronic acid and amine groups on the dendrimer surface (Fig. 2) [20]. The clustered G2 dendrimers exhibited superior DNA and siRNA delivery efficacy to high-generation dendrimers (such as G5), and comparable efficacy to Lipofectamine 2000. More importantly, the assembled nanoparticles could quickly disassemble into low-molecular dendrimers when entrapped in acidic vesicles, leading to significantly decreased toxicity on the transfected cells. The analogue materials without the ability of self-assembly before complexation with DNA showed extremely low transfection efficacy. Both the phenyl and boronic acid groups play essential roles in the assembly and gene-delivery processes. Competitive binding of boronic acid moieties on G2 dendrimer with diols inhibited the formation of assembled nanostructures, and significantly down-regulated its transfection efficacy [20].
Similarly, hydrogen-bonding interaction can be adapted to fabricate nanostructures based on low molecular weight dendrimers. For example, melamine-modified G3 PAMAM dendrimer assembled into nanoparticles around 100 nm in aqueous solution when added with cyanuric acid (Fig. 3) [27, 28]. The formation of nanoparticles was driven by specific hydrogen-bond recognition between melamine and cyanuric acid. Melamine-modified G3 dendrimer alone formed loose polyplexes with plasmid DNA, which could be easily destabilized by polyanionic molecules such as heparin. In comparison, the presence of cyanuric acid significantly increased the polyplex stability via intermolecular hydrogen-bond recognition, and the strengthened polyplex exhibited much improved cellular uptake and transfection efficacy. Furthermore, the addition of cyanuric acid did not induce additional toxicity on the transfected cells. This facile hydrogen-bond recognition strategy is beneficial for low molecular weight polymers in gene delivery.
When a low molecular weight dendron was conjugated with one or two aliphatic chains at the focal point of dendron, the generated amphiphilic polymers could self-assemble into nanostructures via hydrophobic interactions [22, 23, 29,30,31,32,33,34,35,36,37]. The aliphatic chain could be conjugated to the dendron by in situ synthesis, click chemistry, or host–guest interaction (Fig. 4) [22, 31, 38]. The aliphatic chain in the polymer controls the number of dendrons in each assembled nanostructure, as well as the diameter and surface charge density of the nanostructure, while the dendron generation influences its DNA binding and endosomal escape capacity [31, 39]. An amphiphilic polymer bearing a hydrophobic alkyl chain with 18 carbon atoms (C18) and a hydrophilic G1 PAMAM dendron with eight primary amines was capable of assembling into nanomicelles (Fig. 5a2) [22]. The assembled micelle had a similar structure to traditional high-generation dendrimers, and could efficiently deliver DNA and siRNA into various cell lines with minimal toxicity (Fig. 5b) [40]. Similarly, an amphiphilic material consisted of two C18 aliphatic chains and a G2 PAMAM dendron assembled into nanovesicles before siRNA complexation, and achieved high efficacy in gene silencing (Fig. 5a3) [23]. Coarse-grained molecular dynamics simulation was further used to describe how the amphiphilic polymer self-assembled into nanostructures, and to analyze the optimal chain length and dendron generation on siRNA delivery [41]. According to the simulation results, the amphiphilic material with a C18 aliphatic chain and a G2 PAMAM dendron showed the best performance in siRNA binding, which is in accordance with the gene-silencing results reported by Peng et al. [22, 40]. Besides the alkyl chain length and dendron generation, the structure of lipid conjugated to dendron also plays an essential role in gene transfection [42,43,44]. G1 PAMAM dendron conjugated with two unsaturated C18 chains showed significantly increased gene-transfection efficacy compared to the analogue material containing two saturated C18 alkyls, probably due to better DNA packaging and smaller polyplex size (Fig. 5a4) [42]. This result might also be explained by distinct endosomal membrane disruption behaviors [45].
Besides aliphatic chains, hydrophobic ligands such as cholesterol could be anchored to low molecular weight dendrons to generate amphiphilic polymers for efficient gene delivery. Cholesterol is a naturally occurring building block that should be well tolerated in biological systems [46, 47]. The cholesterol-cored dendron with spermine as terminal groups could self-assemble into nanostructures, and disrupt the endosomal membranes via interactions between cholesterol and membrane phospholipids [46]. When cholesterol was conjugated to a degradable aliphatic ester-based dendron with a low molecular weight, the self-assembly will significantly enhance the DNA binding and cellular uptake of unmodified dendrons (Fig. 5a5) [48]. The modification of alkyl chains, cholesterol, or dexamethasone on the surface of low-generation dendrimers also generated amphiphilic materials, which was capable of assembling into various nanostructures [47, 49]. These assembled nanostructures exhibited superior transfection efficacy to non-assembled analogues and better biocompatibility than high-generation dendrimers.
The assembled structures for alkyl chain- and cholesterol-modified dendrons or dendrimers were stable in aqueous solutions, but could be destabilized by phospholipids when penetrating across the cell membranes. To resolve this problem, we can introduce fluoroalkyls to replace the alkyl chain or cholesterol in the supramolecular amphiphiles. Fluoroalkyl chains are both hydrophobic and lipophobic, and the fluorocarbon chains can associate with each other through a fluorophilic effect in both hydrophilic and hydrophobic environments [50]. Percec et al. found that replacement of lipids on a polymer with fluoroalkyls caused drastic changes in the assembled structures [51], and the fluorine made a difference in the self-assembly process [52]. These features are promising for the fabrication of low molecular weight dendrimers into nanostructures via the fluorophilic effect. G1 and G2 PAMAM dendrimers modified with heptafluorobutyric acid molecules assembled into uniform nanoparticles (70−100 nm) with sizes similar to viruses (Fig. 6). The assembled structures could be modulated by tailoring the average number of conjugated heptafluorobutyric acid on the dendrimer surface [24]. Increasing the conjugation number on the dendrimer surface achieved high transfection efficacy at extremely low nitrogen-to-phosphorus ratios. The most efficient assembly showed high transfection efficacy on cells at an ultra-low DNA dose of 20 ng, maintained high efficacy even in the presence of 50% serum, and effectively transfected 3D spheroids and solid tumors in vivo [24, 53]. Since the synthesized materials have low molecular weight and charge density, they showed minimal toxicity on the transfected cells [54]. Besides self-assembly and polyplex stability, fluoroalkyls exhibited other advantages compared to alkyls in gene delivery mediated by amphiphilic dendrimers. First, fluoroalkyls are much more hydrophobic than alkyls with the same number of carbon atoms. As discussed in the section of amphiphilic dendrimers bearing alkyl chains, a long aliphatic chain with 12–18 carbon atoms was usually used to construct efficient amphiphiles. However, only four carbon atoms (heptafluorobutyric acid) were needed to achieve efficient gene delivery for fluoroaklyl-modified dendrimers. In addition, fluorocarbon chains can improve the transfection efficacy of cationic polymers by a “fluorous effect” (increased serum resistance, cellular uptake, endosomal escape, and easier intracellular DNA release) [54,55,56,57,58,59]. Currently, nearly 25% of the marketed drugs contain one or more fluorine atoms. These fluorine-containing drugs such as sorafenib and 5-fluorouracil could be loaded within the assembled fluorodendrimers via fluorophilic interactions [60]. The drug loading did not influence the gene-transfection efficacy of fluorodendrimers. As a result, these fluorophilic effect-driven assemblies enable the co-delivery of therapeutic drugs and genes for synergistic cancer therapy.
3 Anchoring Low-Generation Dendrimers onto Nanoparticles, Proteins, or Polymers
Low-generation dendrimers or dendrons could be grafted on biocompatible nanoparticles, proteins, or polymers via stimuli-responsive linkages to “temporarily” generate hybrid materials with relatively high charge density for efficient and non-toxic gene delivery. Lipoic acid-cored low-generation peptide dendrons were conjugated to the surface of inorganic nanoparticles such as gold, iron oxide, and quantum dots via covalent linkages (Fig. 7a) [25]. This strategy dramatically increased the gene-transfection efficiency of low molecular weight dendrons by approximately 50,000-fold. The linkage such as gold-thiol bond between the dendrons and inorganic nanoparticle was cleavable in the presence of glutathione after endocytosis [61]. As a result, minimal toxicity of the hybrid materials was observed during gene transfection. In addition, the inorganic nanoparticle endows the hybrid materials with new functions in gene delivery, e.g., gold nanoparticles for X-ray computed tomography or combined photothermal therapy, iron oxide nanoparticles for magnetic resonance imaging, and quantum dots (QDs) for fluorescence imaging [25]. The inherent fluorescence could be used to monitor intracellular pathway of the hybrid material as well as the protein expression. Similarly, gold nanoparticles engineered with low molecular weight dendrons showed high efficacy in siRNA delivery. The hybrid material suppressed the expression of a target gene by 50% with minimal toxicity. The dendronized gold nanoparticles possessed high siRNA binding capability like high molecular weight polymers, while minimizing toxicity through the use of non-toxic core functionality (Fig. 7b) [62]. In a separate study, G2 PAMAM dendrimer was conjugated to mesoporous silica nanosphere for efficient gene delivery [63]. The yielded hybrid material could bind plasmid DNA to form stable polyplexes and efficiently deliver the DNA into hard-to-transfect cells such as neural glia cells. Since the mesoporous silica nanoparticles could be loaded with various drugs or proteins [64,65,66], the synthesized hybrid material allows the co-delivery of therapeutic genes and drugs for synergistic therapy. Though these low-generation dendrimer-coated silica nanoparticles showed efficient cellular uptake, their gene-transfection efficacy was not reported, and the cytotoxicity issue should be a problem for this hybrid material because the low molecular weight dendrimer was conjugated on nanoparticle surface via a non-degradable linkage.
Dendrimers could serve as ideal templates to synthesize dendrimer-encapsulated or dendrimer-stabilized nanoparticles such as gold and platinum nanoparticles [67,68,69,70]. When a G3 polypropylenimine (PPI) dendrimer was used as a template to synthesize dendrimer-stabilized gold nanoparticles, the gold nanoparticle in the hybrid material facilitated the low-generation dendrimer on its surface to package siRNA into compact polyplexes (Fig. 7c) [71]. The G3 PPI-stabilized gold nanoparticle showed much higher gene silencing efficacy compared to G3 PPI dendrimer alone, and was even more efficient than a G5 PPI dendrimer. Interestingly, the gold nanoparticles in the hybrid materials were not included in the yielding polyplexes with siRNA, and this property made it possible to eliminate the potential cytotoxicity issues associated with gold nanoparticles, which were selectively removed from the polyplexes before cell endocytosis [71].
Low-generation dendrons could also be attached to the surface of proteins in a site-specific manner to generate dendron-conjugated proteins (Fig. 7d) [72]. The number of dendrons and the anchoring site on protein surface could be precisely controlled. For example, an N-maleimido-cored G1 dendron terminated with spermine was conjugated to thiol groups on the protein surface (e.g., Cys-34 on bovine serum albumin or a genetically engineered cysteine mutant of Class II hydrophobin) via biorthogonal chemistry. The dendron-anchored protein showed high affinity towards plasmid DNA, and exhibited significantly improved gene-transfection efficacy when delivering a plasmid encoding β-galactosidase [72]. The presence of proteins in the hybrid materials did not bring additional toxicity to the low molecular weight dendron on the treated cells.
By grafting low-generation dendrimers or dendrons onto biocompatible polymers such as chitosan, amylose, and polyrotaxane, the transfection efficacy of dendrimer and dendron could be significantly increased due to improved DNA binding and polyplex stability [73,74,75]. G2 and G3 PAMAM dendrons were conjugated to the backbone of a chitosan via click chemistry (Fig. 8a). The dendronized chitosan showed enhanced transfection efficacy compared to free chitosan, low molecular weight dendrons, and polyethyleneimine (PEI) [73]. A G1 PAMAM-grafted polyrotaxane showed higher transfection efficacy, but less cytotoxicity than PEI on different cell lines (Fig. 8b) [75]. The dendrimer-grafted polyrotaxane formed stable polyplexes around 100 nm with plasmid DNA, and the polyplexes were internalized into transfected cells via a caveolae-dependent pathway, which avoided lysosomal degradation after cellular uptake. In addition, the polyplexes were very stable and could maintain the nanoparticle size after 256-fold dilution. This dilution-stable property is essential for in vivo gene therapy because the polyplex solution will be highly diluted when administrated by intravenous injection [75].
Besides the “grafting onto” strategy, we can also adopt a “grafting from” method to fabricate dendrimer-anchored polymers [76,77,78]. Low-generation dendrons could be synthesized on the scaffold of a linear polymer scaffold by a stepwise manner. By synthesizing low-generation PAMAM dendrons on a disulfide-containing polymer via repetitive Michael addition and amidation, a series of bioreducible dendronized polymers were obtained (Fig. 8c) [76]. Since the high charge density on the dendronzied polymer, the material showed strong DNA binding ability and greatly improved transfection efficacy compared to low molecular weight dendrimers. In addition, the dendronized polymer with a reduction-sensitive polymer scaffold was able to degrade into low molecular weight species in the presence of thiols or acids, which allows limited toxicity on the cells. Similarly, peptide-based dendrons were synthesized on a bioreducible polymer to obtain a dendronized polymer for siRNA delivery. The generated polymers also exhibited high delivery efficiency in serum and low toxicity on the cells, and would be a promising non-viral carrier for siRNA delivery [77]. These strategies encourage further design of hybrid materials consisted of low molecular weight dendrimers or dendrons and biocompatible nanoparticles, proteins, or polymers for efficient gene delivery.
4 Crosslinking Low-Generation Dendrimers into Nanoaggregates or Polymers
Low molecular weight dendrimers could be cross-linked into larger nanoclusters by covalent linkages for improved gene transfection. For example, the surface of a G2 PAMAM dendrimer was engineered with multiple G1 PAMAM dendrimers via polyglutamate linkers [79]. The material constructed by G1, G2 dendrimer and polyglutamate showed high efficacy and excellent serum-resistance in gene delivery. In a separate study, G2 PPI dendrimers were reacted with 10-bromodecanoic acid to increase the lipophilicity, and the carboxyl groups on the terminal of aliphatic chain were further reacted with residual amine groups on G2 PPI dendrimer, yielding a nanocluster with improved transfection efficacy [80]. However, low molecular weight dendrimers were crosslinked via non-degradable linkages in these nanoclusters. Though the transfection efficacy is highly improved, the cytotoxicity is still a problem for the nanoclusters due to high charge density on the materials.
If the low molecular weight dendrimers were crosslinked using a stimuli-responsive linker, the fabricated nanoclusters could be degraded into small dendrimers with minimal toxicity in acidic or reductive microenvironments after cell endocytosis. For example, G2 PAMAM dendrimer cross-linked by a disulfide containing linker formed nanoclusters around 40 nm (Fig. 9a). The disulfide-crosslinked G2 dendrimer showed much improved transfection efficacy compared to intact G2 dendrimer, and was superior to a G5 dendrimer [21]. An analogue material cross-linked by a non-degradable linker showed extremely low transfection efficacy, suggesting that the reduction-sensitive property of the degradable linker is essential for efficient gene delivery. Surprisingly, the disulfide-crosslinked G2 dendrimer was even less toxic than intact G2 dendrimer on the transfected cells, probably due to the high density of cationic charges in the interior of fabricated nanoclusters. The cationic charges located in the interior will not cause damage to the cells, and thus minimal toxicity was observed for the synthesized materials [21]. Similarly, disulfide-crosslinked G1 polylysine dendrimer showed high transfection efficacy and low cytotoxicity on different cells [81]. By the combination of fluorination and disulfide crosslinking, an efficient nanocluster was prepared for in vitro and in vivo gene delivery with several unique features, e.g.. inactive surface to resist protein interactions due to the presence of fluorous chains; virus-mimicking surface topography to augment cellular uptake; a fluorous effect mediated efficient cellular uptake, endosome escape, and cytoplasm trafficking; and glutathione-triggered nanocluster degradation and intracellular DNA release [82]. These features together contributed to high efficacy of the fabricated nanoclusters. The studies concluded that disulfide-crosslinked low-generation dendrimers with high transfection efficacy, low toxicity, and low cost are efficient alternatives to high generation dendrimers in gene delivery.
One remaining problem for the disulfide-crosslinked nanoclusters is the difficulty in controlling the nanocluster size. The final nanocluster size depends on lots of parameters such as the ratio of linker to dendrimer, the addition rate of linkers, solvents, and reaction temperature, etc. Therefore, the reproducibility of nanoclusters by this strategy is still a sticky issue. We can address this issue by adopting an alternative strategy to prepare disulfide-crosslinked dendrimer. Low molecular weight dendrimers were firstly modified with protected thiols on its surface, and then the crosslinking reactions were initiated by deprotecting the thiol groups in aqueous solution. The nanocluster size was monitored by dynamic light scattering and the cross-linking reactions could be stopped by eliminating the remaining thiols on dendrimer surface through the addition of excess maleimide molecules (Fig. 9b) [83]. By this strategy, disulfide-crosslinked nanocluster with a desirable size in the range of tens to hundreds of nanometers could be obtained.
Besides using stimuli-responsive linkers, nanoclusters were fabricated by mixing two kinds of hyperbranched polymers with different surface functionalities [84, 85]. A low molecular weight hyperbranched oligoethylenimine modified with phenylboronic acid could react with 1,3-diol-rich hyperbranched polyglycerol via boronic acid-diol linkage, forming a dynamic and reversible nanocluster with relatively high charge density (Fig. 10). The nanocluster exhibited strengthened binding affinity to siRNA compared to low molecular weight oligoethylenimine. The degradation of nanocluster could be triggered by lysosomal acidity, which ensures minimal toxicity of polymers on the cells. In addition, the hydrophobic interior of hyperbranched polyglycerol could be loaded with anticancer drugs such as doxorubicin for synergistic cancer therapy. Very recently, the same group adopted a similar strategy to construct acidity-responsive nanoclusters based on specific recognition between phenylboronic acid and diols [86]. Phenylboronic acid-conjugated cholesterol and hyperbranched oligoethylenimine modified with 1,3-diols formed nanoclusters through a combination of hydrophobic interaction between cholesterols and boronic acid-diol recognition. The formed nanocluster also showed efficient gene transfection and low toxicity in vitro and in vivo.
5 Conclusions
We can fabricate low molecular weight dendrimers or dendrons into different nanostructures for efficient and low toxic gene delivery. The low molecular weight polymers could be assembled into nanoaggregates via ionic, hydrogen-bonding, hydrophobic, or fluorophilic interactions. Alternatively, the low molecular weight polymers could be anchored to biocompatible nanoparticles, proteins, and polymers to generate hybrid nanostructures, or be crosslinked into nanoclusters with stimuli-responsive property. These nanostructures can form stable polyplexes with DNA or siRNA in vitro, and degrade into low molecular weight species in the presence of specific triggers such as endolysosomal acidity, glutathione, and enzymes. The flexible strategies available in the design of supramolecular or hybrid nanostructures allow the design of nanostructures with high transfection efficacy and minimal toxicity on the cells. Though these supramolecular polymers showed impressive efficacy in vitro, further modifications on the assembled polymers or nanostructures are needed to shield the positive charges on the polyplexes to transfer the materials for in vivo gene delivery. For example, we need to attach the polyplex with a responsive polyethylene glycol (PEG) shell to improve its blood circulating time, or with a hyaluronic acid shell to improve its accumulation in breast tumors overexpressing CD44. The technologies to fabricate low generation dendrimers into highly efficient and low toxic nanostructures will have broad applicability for clinical applications.
References
Kannan RM, Nance E, Kannan S, Tomalia DA (2014) J Intern Med 276:579
Svenson S, Tomalia DA (2005) Adv Drug Deliv Rev 57:2106
Tomalia DA, Khanna SN (2016) Chem Rev 116:2705
Esfand R, Tomalia DA (2001) Drug Discov Today 6:427
Shao N, Dai T, Liu Y, Li L, Cheng Y (2014) Soft Matter 10:9153
Haensler J, Szoka FC Jr (1993) Bioconjug Chem 4:372
Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR Jr (1996) Proc Natl Acad Sci USA 93:4897
Yang J, Zhang Q, Chang H, Cheng Y (2015) Chem Rev 115:5274
Hu J, Hu K, Cheng Y (2016) Acta Biomater 35:1
Wang H, Huang Q, Chang H, Xiao J, Cheng Y (2016) Biomater Sci 4:375
Dufes C, Uchegbu IF, Schatzlein AG (2005) Adv Drug Deliv Rev 57:2177
Mastrobattista E, Hennink WE (2011) Nat Mater 11:10
Nam HY, Nam K, Lee M, Kim SW, Bull DA (2012) J Control Release 160:592
Nam K, Jung S, Nam JP, Kim SW (2015) J Control Release 220:447
Pan S, Cao D, Huang H, Yi W, Qin L, Feng M (2013) Macromol Biosci 13:422
Zeng X, Pan S, Li J, Wang C, Wen Y, Wu H, Wang C, Wu C, Feng M (2011) Nanotechnology 22:375102
Zhou J, Liu J, Cheng CJ, Patel TR, Weller CE, Piepmeier JM, Jiang Z, Saltzman WM (2011) Nat Mater 11:82
Breunig M, Lungwitz U, Liebl R, Goepferich A (2007) Proc Natl Acad Sci USA 104:14454
Gosselin MA, Guo W, Lee RJ (2001) Bioconjug Chem 12:989
Liu C, Shao N, Wang Y, Cheng Y (2016) Adv Healthc Mater 5:584
Liu H, Wang H, Yang W, Cheng Y (2012) J Am Chem Soc 134:17680
Yu T, Liu X, Bolcato-Bellemin AL, Wang Y, Liu C, Erbacher P, Qu F, Rocchi P, Behr JP, Peng L (2012) Angew Chem Int Ed Engl 51:8478
Liu X, Zhou J, Yu T, Chen C, Cheng Q, Sengupta K, Huang Y, Li H, Liu C, Wang Y, Posocco P, Wang M, Cui Q, Giorgio S, Fermeglia M, Qu F, Pricl S, Shi Y, Liang Z, Rocchi P, Rossi JJ, Peng L (2014) Angew Chem Int Ed Engl 53:11822
Wang H, Wang Y, Wang Y, Hu J, Li T, Liu H, Zhang Q, Cheng Y (2015) Angew Chem Int Ed Engl 54:11647
Xu X, Jian Y, Li Y, Zhang X, Tu Z, Gu Z (2014) ACS Nano 8:9255
Dong R, Zhou Y, Zhu X (2014) Acc Chem Res 47:2006
Shao N, Dai T, Liu Y, Cheng Y (2015) Chem Commun (Camb) 51:9741
Shao N, Liu Y, Dai T, Cheng Y (2015) J Control Release 213:e82
Wei T, Chen C, Liu J, Liu C, Posocco P, Liu X, Cheng Q, Huo S, Liang Z, Fermeglia M, Pricl S, Liang XJ, Rocchi P, Peng L (2015) Proc Natl Acad Sci USA 112:2978
Liu X, Liu C, Zhou J, Chen C, Qu F, Rossi JJ, Rocchi P, Peng L (2015) Nanoscale 7:3867
Kono K, Ikeda R, Tsukamoto K, Yuba E, Kojima C, Harada A (2012) Bioconjug Chem 23:871
Malhotra S, Bauer H, Tschiche A, Staedtler AM, Mohr A, Calderon M, Parmar VS, Hoeke L, Sharbati S, Einspanier R, Haag R (2012) Biomacromol 13:3087
Takahashi T, Kojima C, Harada A, Kono K (2007) Bioconjug Chem 18:1349
Kono K, Murakami E, Hiranaka Y, Yuba E, Kojima C, Harada A, Sakurai K (2011) Angew Chem Int Ed Engl 50:6332
Takahashi T, Harada A, Emi N, Kono K (2005) Bioconjug Chem 16:1160
Takahashi T, Kono K, Itoh T, Emi N, Takagishi T (2003) Bioconjug Chem 14:764
Harada A, Kimura Y, Kojima C, Kono K (2010) Biomacromol 11:1036
Yang B, Dong X, Lei Q, Zhuo R, Feng J, Zhang X (2015) ACS Appl Mater Interfaces 7:22084
Jones SP, Gabrielson NP, Wong CH, Chow HF, Pack DW, Posocco P, Fermeglia M, Pricl S, Smith DK (2011) Mol Pharm 8:416
Chen C, Posocco P, Liu X, Cheng Q, Laurini E, Zhou J, Liu C, Wang Y, Tang J, Col VD, Yu T, Giorgio S, Fermeglia M, Qu F, Liang Z, Rossi JJ, Liu M, Rocchi P, Pricl S, Peng L (2016) Small 12:3604
Marquez-Miranda V, Araya-Duran I, Camarada MB, Comer J, Valencia-Gallegos JA, Gonzalez-Nilo FD (2016) Sci Rep 6:29436
Yuba E, Nakajima Y, Tsukamoto K, Iwashita S, Kojima C, Harada A, Kono K (2012) J Control Release 160:552
Ewert KK, Evans HM, Zidovska A, Bouxsein NF, Ahmad A, Safinya CR (2006) J Am Chem Soc 128:3998
Zhang Y, Chen J, Xiao C, Li M, Tian H, Chen X (2013) Biomacromol 14:4289
Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, Sah DW, Stebbing D, Crosley EJ, Yaworski E, Hafez IM, Dorkin JR, Qin J, Lam K, Rajeev KG, Wong KF, Jeffs LB, Nechev L, Eisenhardt ML, Jayaraman M, Kazem M, Maier MA, Srinivasulu M, Weinstein MJ, Chen Q, Alvarez R, Barros SA, De S, Klimuk SK, Borland T, Kosovrasti V, Cantley WL, Tam YK, Manoharan M, Ciufolini MA, Tracy MA, de Fougerolles A, MacLachlan I, Cullis PR, Madden TD, Hope MJ (2010) Nat Biotechnol 28:172
Jones SP, Gabrielson NP, Pack DW, Smith DK (2008) Chem Commun 39:4700
Morales-Sanfrutos J, Megia-Fernandez A, Hernandez-Mateo F, Giron-Gonzalez MD, Salto-Gonzalez R, Santoyo-Gonzalez F (2011) Org Biomol Chem 9:851
Barnard A, Posocco P, Pricl S, Calderon M, Haag R, Hwang ME, Shum VW, Pack DW, Smith DK (2011) J Am Chem Soc 133:20288
Kim JY, Ryu JH, Hyun H, Kim HA, Choi JS, Yun Lee D, Rhim T, Park JH, Lee M (2012) J Drug Target 20:667
Xiao Q, Rubien JD, Wang Z, Reed EH, Hammer DA, Sahoo D, Heiney PA, Yadavalli SS, Goulian M, Wilner SE, Baumgart T, Vinogradov SA, Klein ML, Percec V (2016) J Am Chem Soc 138:12655
Percec V, Glodde M, Johansson G, Balagurusamy VS, Heiney PA (2003) Angew Chem Int Ed Engl 42:4338
Tomalia DA (2003) Nat Mater 2:711
Wang H, Wang Y, Liu H, Zhang Q, Cheng Y (2015) J Control Release 213:e42
He B, Wang Y, Shao N, Chang H, Cheng Y (2015) Acta Biomater 22:111
Wang M, Liu H, Li L, Cheng Y (2014) Nat Commun 5:3053
Liu H, Wang Y, Wang M, Xiao J, Cheng Y (2014) Biomaterials 35:5407
Wang M, Cheng Y (2014) Biomaterials 35:6603
Wang M, Cheng Y (2016) Acta Biomater 46:204
Shen W, Wang H, Linghu Y, Lv J, Chang H, Cheng Y (2016) J. Mater. Chem. B 4:6468
Wang H, Hu J, Cai X, Xiao J, Cheng Y (2016) Polym Chem 7:2319
Wang X, Cai X, Hu J, Shao N, Wang F, Zhang Q, Xiao J, Cheng Y (2013) J Am Chem Soc 135:9805
Kim ST, Chompoosor A, Yeh YC, Agasti SS, Solfiell DJ, Rotello VM (2012) Small 8:3253
Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VS (2004) J Am Chem Soc 126:13216
Yu C, Qian L, Ge J, Fu J, Yuan P, Yao SC, Yao SQ (2016) Angew Chem Int Ed Engl 55:9272
Chang FP, Chen YP, Mou CY (2014) Small 10:4785
Wu M, Meng Q, Chen Y, Du Y, Zhang L, Li Y, Zhang L, Shi J (2015) Adv Mater 27:215
Zhou Z, Wang Y, Yan Y, Zhang Q, Cheng Y (2016) ACS Nano 10:4863
Liu H, Xu Y, Wen S, Chen Q, Zheng L, Shen M, Zhao J, Zhang G, Shi X (2013) Chemistry 19:6409
Kong L, Alves CS, Hou W, Qiu J, Mohwald H, Tomas H, Shi X (2015) ACS Appl Mater Interfaces 7:4833
Shan Y, Luo T, Peng C, Sheng R, Cao A, Cao X, Shen M, Guo R, Tomas H, Shi X (2012) Biomaterials 33:3025
Chen AM, Taratula O, Wei D, Yen HI, Thomas T, Thomas TJ, Minko T, He H (2010) ACS Nano 4:3679
Kostiainen MA, Szilvay GR, Lehtinen J, Smith DK, Linder MB, Urtti A, Ikkala O (2007) ACS Nano 1:103
Deng J, Zhou Y, Xu B, Mai K, Deng Y, Zhang LM (2011) Biomacromol 12:642
Mai K, Lin J, Zhuang B, Li X, Zhang LM (2015) Int J Biol Macromol 79:209
Huang H, Cao D, Qin L, Tian S, Liang Y, Pan S, Feng M (2014) Mol Pharm 11:2323
Xue YN, Liu M, Peng L, Huang SW, Zhuo RX (2010) Macromol Biosci 10:404
Zeng H, Little HC, Tiambeng TN, Williams GA, Guan Z (2013) J Am Chem Soc 135:4962
Gossl I, Shu L, Schluter AD, Rabe JP (2002) J Am Chem Soc 124:6860
Wu HM, Pan SR, Chen MW, Wu Y, Wang C, Wen YT, Zeng X, Wu CB (2011) Biomaterials 32:1619
Ariaee FM, Hashemi M, Farzad SA, Abnous K, Ramezani M (2016) Iran J Basic Med Sci 19:1096
Li CY, Wang HJ, Cao JM, Zhang J, Yu XQ (2014) Eur J Med Chem 87:413
Cai X, Jin R, Wang J, Yue D, Jiang Q, Wu Y, Gu Z (2016) ACS Appl Mater Interfaces 8:5821
Huang CH, Nwe K, Al Zaki A, Brechbiel MW, Tsourkas A (2012) ACS Nano 6:9416
Jia HZ, Zhang W, Zhu JY, Yang B, Chen S, Chen G, Zhao YF, Feng J, Zhang XZ (2015) J Control Release 216:9
Jia HZ, Zhang W, Wang XL, Yang B, Chen WH, Chen S, Chen G, Zhao YF, Zhuo RX, Feng J, Zhang XZ (2015) Biomater Sci 3:1066
Zhu JY, Zeng X, Qin SY, Wan SS, Jia HZ, Zhuo RX, Feng J, Zhang XZ (2016) Biomaterials 83:79
Acknowledgments
We thank financial supports from the National Natural Science Foundation of China (No. 81601587, No. 21474030) and the Science and Technology Commission of Shanghai Municipality (17XD1401600 and 148014518).
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection “Polymeric Gene Delivery Systems”; edited by Yiyun Cheng.
Rights and permissions
About this article
Cite this article
Wang, H., Chang, H., Zhang, Q. et al. Fabrication of Low-Generation Dendrimers into Nanostructures for Efficient and Nontoxic Gene Delivery. Top Curr Chem (Z) 375, 62 (2017). https://doi.org/10.1007/s41061-017-0151-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s41061-017-0151-6